As part of their Anti-Counterfeit Strategy, the MHRA have recently been focusing on the UK Pharmaceutical Supply Chain and making recommendations for change. In particular the position of the professional Responsible Person has been reviewed, in order to clearly define their roles and responsibilities in safeguarding product integrity from the manufacturer through to the patient.
Introduced in response to these challenges, our highly acclaimed training courses are attracting a wide range of clients wishing to gain the necessary business critical insights provided by both a leading industry expert and a representative of the regulatory authorities.
Introduced in response to these challenges, our highly acclaimed training courses are attracting a wide range of clients wishing to gain the necessary business critical insights provided by both a leading industry expert and a representative of the regulatory authorities.
